Read time: 8 minutes | Updated July 2026

| Do mushrooms improve brain health? Some mushrooms, particularly lion’s mane, show real promise for brain health in early research. A 2009 trial in Phytotherapy Research found lion’s mane improved mild cognitive impairment scores versus placebo. But most human studies are small and short-term, so the evidence is encouraging rather than conclusive. |
Walk into any health food store and you will find lion’s mane mushroom sitting next to bold claims about memory, focus, and even dementia prevention. The packaging is confident. The science is considerably more cautious. Research into mushrooms brain health benefits is genuinely exciting, with early findings pointing to real biological mechanisms worth understanding. But there is a wide gap between what the studies actually show and what supplement brands tell you they show.
This is not a piece telling you mushrooms are a miracle, and it is not a piece telling you to ignore them. Lion’s mane, reishi, and chaga each have a growing body of research behind them: some compelling, some preliminary, and some funded by parties with a commercial interest in the outcome. Knowing which is which is the whole point.
Here is what the peer-reviewed research actually says about functional mushrooms and cognitive function, and what a cautious, evidence-based approach looks like in practice.
Lion’s Mane: The Most Studied Mushroom for Cognitive Function

Lion’s mane (Hericium erinaceus) is the most researched mushroom for brain health, and for good reason. It contains two families of compounds, hericenones and erinacines, that laboratory studies suggest may stimulate the production of nerve growth factor (NGF), a protein that supports the survival and function of neurons. The picture is not fully settled: some research indicates the NGF-stimulating activity may not come from the hericenones themselves, even though whole-mushroom extracts do promote NGF expression in the lab.
The important caveat: NGF does not cross the blood-brain barrier cleanly. Much of the in-vitro and animal work showing NGF stimulation does not automatically translate into the same effect in the living human brain. This is the central limitation that most lion’s mane marketing quietly sidesteps.
That said, the human trial data, while modest, is real. A 2009 randomised controlled trial in Phytotherapy Research by Mori and colleagues tested lion’s mane in 30 adults with mild cognitive impairment over 16 weeks. The supplementation group showed significantly improved cognitive scores versus placebo, though scores declined again after the intervention ended. A longer 49-week study in Frontiers in Aging Neuroscience using an erinacine A-enriched mycelia preparation reported improvements in cognitive and daily-living scores in patients with mild Alzheimer’s. Both are small, early-stage studies.
The most accurate summary is this: the mechanism is biologically plausible, the early human data is promising, and larger long-term trials are needed before strong claims can be made. That is a meaningful distance from “lion’s mane reverses dementia,” which you will find on many supplement labels.
Reishi: The Anti-Inflammatory Angle

Reishi (Ganoderma lucidum) takes a different route. Rather than directly stimulating neuronal growth factors, reishi is studied primarily for anti-inflammatory and adaptogenic properties. Chronic neuroinflammation is increasingly recognised as a mechanism involved in the progression of neurodegenerative disease. A 2013 study in Experimental and Therapeutic Medicine found that a Ganoderma lucidum extract suppressed NF-kB and toll-like receptor inflammatory pathways in microglial cells, the brain’s resident immune cells.
The sleep connection is worth noting separately. In an animal study published in Pharmacology, Biochemistry and Behavior, reishi extract shortened the time it took to fall asleep and increased total sleep time through what appears to be a GABAergic mechanism, since the effect was blocked by a benzodiazepine receptor antagonist. Given that poor sleep is one of the most well-established modifiable risk factors for Alzheimer’s disease, a supplement that genuinely improves sleep has an indirect but meaningful pathway to cognitive protection. The evidence here is early and mostly preclinical, but not implausible.
Reishi is also one of the most extensively used medicinal mushrooms in traditional Chinese medicine, which gives it a long safety track record. That is not the same as clinical efficacy evidence, but it matters for tolerability.
Chaga: Antioxidants and Open Questions

Chaga (Inonotus obliquus) is perhaps the most overhyped of the three. It is frequently marketed as an “antioxidant powerhouse” with broad brain-protective claims. The antioxidant content is real: chaga has very high ORAC values, largely from its melanin and polyphenol content. The brain health claims are considerably more speculative.
Most chaga research relevant to the brain is preclinical, meaning it was conducted in cell cultures or animal models. A 2019 study in the International Journal of Biological Macromolecules found that chaga polysaccharides protected against Alzheimer’s-related damage through Nrf2 antioxidant signaling, with antioxidative and antiapoptotic effects in damaged neuronal cells and animal models. Interesting, but such models have a poor track record of translating to human outcomes, and no human cognitive trials on chaga have been published to date.
Chaga also contains oxalates at high levels, and the oxalate content is highest in the hot-water extracts most people drink as tea. Published case reports have linked heavy, long-term chaga use to oxalate-related kidney damage, in some cases severe. This is not a reason to never consume chaga, but it is a reason to be cautious about the daily high-dose supplementation some wellness influencers promote. Occasional chaga tea is likely fine; daily high-dose use is a different question.
What the Research Actually Shows: Three Studies Worth Knowing

Cutting through the marketing, here are the three most important studies currently shaping the evidence base for mushrooms and cognitive function.
1. The Mori et al. Lion’s Mane RCT (2009)
This remains the most-cited human trial. Thirty Japanese adults with mild cognitive impairment took 3g of lion’s mane powder daily for 16 weeks (Phytotherapy Research). Cognitive scores improved significantly versus placebo at weeks 8, 12, and 16. The limitation: effects reversed after supplementation stopped, and the sample was small. A promising signal, not a definitive result.
2. The Nagano et al. Study on Mood and Anxiety (2010)
A 2010 study in Biomedical Research tested lion’s mane in 30 women over four weeks and found reduced depression and anxiety scores. This study measured mood and stress rather than cognition directly, which matters because chronic stress and elevated cortisol are associated with accelerated cognitive decline. A mushroom that genuinely reduces perceived stress may have an indirect neuroprotective pathway even if direct effects on the brain remain unconfirmed. Notably, the authors suggested the mood benefit worked through a mechanism separate from NGF.
3. The 2023 Northumbria Randomised Trial
A 2023 randomised trial in Nutrients from Northumbria University in the UK tested lion’s mane in 41 healthy adults aged 18 to 45. A single dose improved processing speed on the Stroop task, and 28 days of supplementation produced a trend toward reduced subjective stress that fell just short of statistical significance. The trial did not find a working-memory benefit. It is one of the more rigorous recent human studies, though the sample was small and the participants were young and cognitively healthy, so it tells us less about dementia prevention specifically.
What a Sensible Approach Actually Looks Like

The evidence supports cautious optimism. If you are interested in trying lion’s mane specifically, the human trial data justifies doing so. The evidence for chaga and reishi as standalone cognitive interventions is weaker, though both have reasonable safety profiles and other potential benefits.
More importantly, medicinal mushrooms are not a substitute for the lifestyle factors with far stronger evidence behind them. The research on exercise and Alzheimer’s prevention is considerably more robust than anything in the mushroom literature, and the same holds for sleep, diet quality, and stress management. As someone who cycles and plays padel several times a week, I will admit the appeal of a shortcut in a jar. The honest read is that movement, sleep, and food do the heavy lifting. Mushrooms may play a supporting role. They should not headline the strategy.
For nutrition specifically, the evidence for whole-food sources of brain-protective compounds is stronger than for any single mushroom supplement. Adding lion’s mane to an already solid nutritional base makes more sense than using it as a shortcut around one. Exploring what the broader research says on foods that reduce dementia risk gives you a more complete picture.
Practical Action Steps
- If you want to try lion’s mane, choose whole-mushroom powder over isolate extracts. Products standardised to contain both hericenones and erinacines have a better theoretical basis. Look for third-party tested brands. The dose used in the Mori trial was 3g daily.
- Do not expect results in two weeks. The positive human trials ran 16 weeks or longer. If you try it, commit to at least 12 weeks before evaluating.
- Prioritise food sources first. Culinary mushrooms such as shiitake, oyster, and maitake contain ergothioneine, an antioxidant some researchers believe may be neuroprotective. Eating these regularly is lower cost and better studied than supplementing with extracts.
- Do not use high-dose chaga long-term without medical guidance. The oxalate content is a genuine concern with chronic high-dose use, especially as tea. Occasional chaga tea is likely fine; daily high-dose supplementation is a different question.
- Stack with, not instead of, established interventions. Mushroom supplementation is no substitute for aerobic exercise, quality sleep, or a Mediterranean-style diet. The evidence base for those is an order of magnitude stronger.
The Bottom Line
The research on mushrooms brain health benefits is genuinely promising, especially for lion’s mane, and it deserves more rigorous study than it has received. What it does not yet deserve is the confidence you see in most supplement marketing. The human trial data is encouraging but limited, the mechanistic pathways are plausible but not proven, and the safety profiles are generally good.
If you are already doing the basics well, getting seven to eight hours of sleep, exercising regularly, eating a diet rich in whole foods, and managing chronic stress, then adding lion’s mane is a reasonable experiment with limited downside. If you are not yet doing those things, start there. No mushroom supplement closes the gap that an inactive lifestyle, poor sleep, or a high ultra-processed diet creates.
Want more research-backed brain health strategies delivered to your inbox every week? Join our free newsletter and get the 5 Science-Backed Habits guide instantly.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine.
Frequently Asked Questions
Does lion’s mane mushroom actually help with memory?
Early human studies suggest lion’s mane may improve mild cognitive impairment and processing speed, but the trials are small and short-term. The most robust involved around 30 to 41 participants over a few months to just under a year. The biological mechanism is plausible, but larger long-term randomised trials are needed before firm conclusions can be drawn about memory benefits in healthy adults.
Which mushroom is best for brain health?
Lion’s mane has the most human trial data supporting cognitive benefits and is the best-studied functional mushroom for brain health specifically. Reishi has stronger evidence for anti-inflammatory and sleep-related effects. Chaga’s brain health evidence is largely preclinical. For direct cognitive support, lion’s mane is currently the most evidence-backed option, though the overall research base remains limited.
How long does lion’s mane take to work?
The most-cited human trial ran 16 weeks before significant cognitive improvements were measured. Most researchers suggest giving supplementation at least 8 to 12 weeks before evaluating. Effects seen in short trials of two to four weeks tend to reflect mood and stress reduction rather than measurable cognitive change.
Are medicinal mushroom supplements safe?
Lion’s mane and reishi have good general safety profiles based on both trial data and long traditional use. Chaga contains high oxalate levels and may pose kidney risks with chronic high-dose supplementation, particularly as tea. As with any supplement, people on blood-thinning medication or with autoimmune conditions should consult a healthcare provider first. Most adverse effects reported in the literature are mild and gastrointestinal.
Related Reading
For the broader picture on nutrition and brain health, see what the evidence says about foods that reduce dementia risk. If you are interested in supplement research more broadly, whether omega-3 can really help prevent Alzheimer’s disease covers one of the most studied areas. And if stress is a factor for you, the research connecting cortisol and memory loss is worth understanding alongside this piece.
Sources
- Mori K, et al. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research. PMID 18844328.
- Nagano M, et al. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research. PMID 20834180.
- Docherty S, Doughty FL, Smith EF (2023). The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults. Nutrients. PMID 38004235.
- Li IC, et al. (2020). Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia: Pilot Double-Blind Placebo-Controlled Study. Frontiers in Aging Neuroscience. PMID 32581767.
- Yoon HM, et al. (2013). Ganoderma lucidum ethanol extract inhibits the inflammatory response by suppressing the NF-kB and toll-like receptor pathways in LPS-stimulated BV2 microglial cells. Experimental and Therapeutic Medicine. PMID 23408713.
- Chu QP, et al. (2007). Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism. Pharmacology, Biochemistry and Behavior. PMID 17383716.
- Han Y, et al. (2019). Inonotus obliquus polysaccharides protect against Alzheimer’s disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects. International Journal of Biological Macromolecules. PMID 30878614.
- Wachtel-Galor S, et al. (2011). Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. In: Herbal Medicine: Biomolecular and Clinical Aspects, 2nd edition.